{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:35:01Z","timestamp":1784194501698,"version":"3.55.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Japanese encephalitis (JE) vaccination is the most effective measure for preventing JE disease. The live attenuated JE vaccine, which has shown good efficacy and safety, has been widely used in China.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentations<\/jats:title>\n            <jats:p>We report four laboratory-confirmed JE cases detected in JE-endemic areas during the JE virus (JEV) transmission season, who all received a first dose of live attenuated JE vaccine within 2 weeks prior to the onset of illness. All cases presented with acute encephalitis and rapidly reduced consciousness. All cerebrospinal fluid (CSF) samples from the patients were positive for JEV-specific immunoglobulin M (IgM) antibodies, but viral isolation and polymerase chain reaction (PCR) detection of JEV were both negative.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>It is difficult to identify a causal link between the disease and the vaccination, as the source of positive CSF JEV IgM antibodies might be natural JEV infection or possibly due to a traumatic lumbar puncture. Our observations highlight the need for public health officers and doctors to consider reasonable vaccination policies during the JE season. In addition, continued surveillance as well as thorough investigation of any events that occur after JE vaccination is necessary.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-11-344","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T19:24:12Z","timestamp":1323890652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports"],"prefix":"10.1186","volume":"11","author":[{"given":"Na","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Xia","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Qing","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Fang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiu-Song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,14]]},"reference":[{"key":"1697_CR1","doi-asserted-by":"publisher","first-page":"e624","DOI":"10.1371\/journal.pntd.0000624","volume":"4","author":"X Gao","year":"2010","unstructured":"Gao X, Nasci R, Liang G: The neglected arboviral infections in mainland China. PLoS Negl Trop Dis. 2010, 4: e624-10.1371\/journal.pntd.0000624.","journal-title":"PLoS Negl Trop Dis"},{"key":"1697_CR2","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/S0140-6736(96)91075-2","volume":"347","author":"S Hennessy","year":"1996","unstructured":"Hennessy S, Liu Z, Tsai TF, Strom BL, Wan CM, Liu HL: Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet. 1996, 347: 1583-1586. 10.1016\/S0140-6736(96)91075-2.","journal-title":"Lancet"},{"key":"1697_CR3","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1016\/j.vaccine.2007.04.052","volume":"25","author":"JB Tandan","year":"2007","unstructured":"Tandan JB, Ohrr H, Sohn YM, Yoksan S, Ji M, Nam CM: Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. Vaccine. 2007, 25: 5041-5045. 10.1016\/j.vaccine.2007.04.052.","journal-title":"Vaccine"},{"key":"1697_CR4","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1086\/517323","volume":"176","author":"ZL Liu","year":"1997","unstructured":"Liu ZL, Hennessy S, Strom BL, Tsai TF, Wan CM, Tang SC: Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects. J Infect Dis. 1997, 176: 1366-1369. 10.1086\/517323.","journal-title":"J Infect Dis"},{"key":"1697_CR5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1988.39.214","volume":"39","author":"YY Xin","year":"1988","unstructured":"Xin YY, Ming ZG, Peng GY, Jian A, Min LH: Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg. 1988, 39: 214-217.","journal-title":"Am J Trop Med Hyg"},{"key":"1697_CR6","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/S0264-410X(99)00006-7","volume":"17","author":"YM Sohn","year":"1999","unstructured":"Sohn YM, Park MS, Rho HO, Chandler LJ, Shope RE, Tsai TF: Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants. Vaccine. 1999, 17: 2259-2264. 10.1016\/S0264-410X(99)00006-7.","journal-title":"Vaccine"},{"key":"1697_CR7","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1086\/651271","volume":"50","author":"SB Halstead","year":"2010","unstructured":"Halstead SB, Thomas SJ: Japanese encephalitis: new options for active immunization. Clin Infect Dis. 2010, 50: 1155-1164. 10.1086\/651271.","journal-title":"Clin Infect Dis"},{"key":"1697_CR8","first-page":"43","volume":"16","author":"WX Zheng","year":"2005","unstructured":"Zheng WX, Wang WX: Allergic reactions after Japanese Encephalitis vaccination in China: a pooled data analysis. J Pub Health Pre Med. 2005, 16: 43-44. [in Chinese]","journal-title":"J Pub Health Pre Med"},{"key":"1697_CR9","first-page":"1","volume":"24","author":"SZ Deng","year":"2009","unstructured":"Deng SZ, Zhang HL, Liu XQ: Analysis of epidemiological characteristics of Japanese encephalitis in Yunnan province from 1976 to 2007. Endem Dis Bull. 2009, 24: 1-7. [in Chinese]","journal-title":"Endem Dis Bull"},{"key":"1697_CR10","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3201\/eid1307.070010","volume":"13","author":"LH Wang","year":"2007","unstructured":"Wang LH, Fu SH, Wang HY, Liang XF, Cheng JX, Jing HM, Ze WY, Lv XJ, Wang HQ, Zhang DL, Feng Y, Yin ZD, Sun XH, Shui TJ, Li XH, Li YX, Liang GD: Japanese encephalitis outbreak, Yuncheng, China, 2006. Emerg Infect Dis. 2007, 13: 1123-1125.","journal-title":"Emerg Infect Dis"},{"key":"1697_CR11","unstructured":"Japanese Encephalitis Vaccine: WHO Position Paper. Aug 2006: Selected references. [http:\/\/www.who.int\/entity\/immunization\/Refs_JE_Aug_3_2006.pdf]"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-11-344\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:13:58Z","timestamp":1630520038000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-11-344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1697"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-11-344","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"19 October 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"344"}}